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Background: Many Muslim diabetes patients choose to participate in Ramadan despite medical advice to the
contrary. This study aims to describe Qatar pharmacists’ practice, knowledge, and attitudes towards guiding
diabetes medication management during Ramadan.
Methods: A cross-sectional descriptive study was performed among a convenience sample of 580 Qatar pharmacists.
A web-based questionnaire was systematically developed following comprehensive literature review and structured
according to 4 main domains: subject demographics; diabetes patient care experiences; knowledge of appropriate
patient care during Ramadan fasting; and attitudes towards potential pharmacist responsibilities in this regard.
Results: In the 3 months prior to Ramadan (July 2012), 178 (31%) pharmacists responded to the survey. Ambulatory
(103, 58%) and inpatient practices (72, 41%) were similarly represented. One-third of pharmacists reported at least
weekly interaction with diabetes patients during Ramadan. The most popular resources for management advice were
the internet (94, 53%) and practice guidelines (80, 45%); however only 20% were aware of and had read the American
Diabetes Association Ramadan consensus document. Pharmacist knowledge scores of appropriate care was overall fair
(99, 57%). Pharmacists identified several barriers to participating in diabetes management including workload and lack
of private counseling areas, but expressed attitudes consistent with a desire to assume greater roles in advising fasting
diabetes patients.
Conclusion: Qatar pharmacists face several practical barriers to guiding diabetes patient self-management during
Ramadan, but are motivated to assume a greater role in such care. Educational programs are necessary to improve
pharmacist knowledge in the provision of accurate patient advice.
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Ramadan is the holy month of fasting in which Muslims
refrain from food, fluids, oral medications and smoking
from sunrise until sunset. The Koran specifically exempts
from fasting those for whom it may have harmful conse-
quences, such as pregnant women, the elderly and those
with medical conditions. Fasting is not recommended for
type 1 diabetes patients, those who are non-adherent to
therapy or who have poor glycemic control [1]. These in-
dividuals in particular are at increased risk of hypo- and
hyperglycemic episodes as well as metabolic complications
associated with dehydration [2]. However, many diabetes
patients choose to participate despite the medical and reli-
gious advice excusing them from the Ramadan fast [3-5].* Correspondence: kwilbur@qu.edu.qa
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Ramadan have been proposed by international medical
and religious bodies [1,6-9]. General considerations in-
clude pre-Ramadan medical assessment and patient edu-
cation regarding meal planning; physical activity; the need
for increased frequency of blood glucose monitoring and
the recognition and management of acute complications.
Recommendations for diabetes medication dosing adjust-
ments tailored for both type 1 and type 2 diabetes patients
are also outlined. Despite availability of such resources,
studies have identified gaps in prescribed diabetes patient
care, notably inappropriate health professional discourage-
ment towards fasting and lack of counseling regarding
medications or instructions for breaking the fast [10-12].
Regions with the highest diabetes prevalence world-
wide are currently found in Gulf Coast Countries (GCC)Ltd. This is an Open Access article distributed under the terms of the Creative
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sula in the Persian Gulf where estimates of diagnosed
diabetes among its population of 1.9 million have ranged
from 12% (all residents) to 17% (among Qatari only)
[14,15]. Qatar boasts an emerging economy and is re-
cently devoting significant resources to develop its health
care infrastructure, with emphasis on primary health care,
including enhancing roles of community pharmacy
[16,17]. Provision of health and medication education as-
sociated with Ramadan is a vehicle for such expansion of
pharmacist scope of practice and patient expectations
thereof. Pharmacists, especially in ambulatory care prac-
tices, are easily accessible by patients and can assume an
important role in ensuring safe fasting for diabetes pa-
tients; however, no studies on such pharmacist care have
been reported. The objective of this study is to explore
Qatar pharmacists’ current practice, knowledge and atti-
tudes towards guiding diabetes patient management dur-
ing Ramadan.
Methods
A comprehensive English language literature review
was conducted in pertinent electronic health databases
(PubMed, EMBASE, IPA, CINAHL: 1990-January 2011)
and Google and Google Scholar search engines using
combination of predetermined key words, “diabetes”;
“Ramadan”; “fast”; ““pharmacist”; “attitudes”; “percep-
tions”; “experiences”; “knowledge”; “barriers”. Online re-
sources of multinational organizations, such as the World
Health Organization and International Diabetes Fe-
deration were verified. Online resources were simi-
larly searched using key words in Arabic. Hand-search of
references of retrieved articles was also performed. Cli-
nical practice guidelines, consensus statements, reviews or
reports outlining diabetes patient management during
Ramadan, and any research pertaining to health profes-
sional fasting diabetes patient care experience were evalu-
ated and adapted for development of our questionnaire.
Survey questions were structured according to 4 main
domains: subject demographics; diabetes patient care ex-
periences; knowledge of appropriate patient care during
Ramadan fasting; and attitudes towards potential phar-
macist responsibilities in this regard. The section as-
sessing respondent knowledge consisted of a series of
questions related to recommendations for diabetes pa-
tient medical assessments and drug dosing derived from
published clinical practice guidelines and evidence-based
reviews [1,6-9]. Areas evaluated pertained to risks to dia-
betes patients during fasting (seven statements); patient
risk stratification (twelve statements); recommendations
for referral and evaluation (twenty nine statements); drug
dosing adjustment (three statements); and safety parame-
ters for prematurely breaking the fast (two statements).
One mark was awarded for each appropriate answer, witha maximum obtainable correct score of 53. An arbi-
trary scoring system categorized overall level of know-
ledge assessed as poor (0–25), moderate (26–40) and
good (41–53). A further twenty-seven statements addres-
sing pharmacist attitudes towards perceived barriers
(14) and opportunities (6), as well as motivations (7)
for expanding roles in diabetes care management during
Ramadan. A five-point Likert scale ranging from “Strongly
Agree” to “Strongly Disagree” was used to assess the res-
ponses of the participants.
A draft survey was then reviewed for face and content
validity by a small working group comprised of three
senior pharmacist members of Qatar University (QU)
College of Pharmacy (CPH) faculty and staff and two li-
censed pharmacists. Modifications were made based on
feedback provided and consensus reached among all in-
volved in revising the questionnaire.
The questionnaire was formatted as an electronic sur-
vey (SurveyMonkey® program) and piloted by a small
randomly selected group of pharmacists, after which no
necessary design changes were made. Reliability testing
was conducted for the attitude responses results showing
internal consistency of the items tested with Cronbach’s
α value of 0.75.
Qatar is an emerging economy but its infrastructure
for health professionals lags behind that of developed
countries. In the absence of a national pharmacy regula-
tory body, there is no complete database of pharmacists
working in Qatar [18]. The Qatar University College of
Pharmacy maintains an independent internal database of
580 pharmacist contacts which represents 75%-80% of
all pharmacists practicing in the country. This conveni-
ence sample of pharmacists employed within documented
public and private health care facilities were invited to par-
ticipate in the survey.
Pharmacists were invited by email to participate in the
anonymous web-based survey that remained open for re-
sponse over a 3-month period prior to Ramadan in July
2012. Email reminders were sent at designated intervals at
2, 4, 6, and 8 and 10 weeks. The research proposal was ap-
proved by the QU Institutional Review Board (IRB).
Frequencies of correct answers to knowledge questions
were assessed. To simplify analysis of the 5-point Likert
scale employed for attitude questions, we classified those
who answered “Strongly Agree” and “Agree” as having
agreed and those who answered “Strongly Disagree” and
“Disagree” as having disagreed. Categorical data is pre-
sented as percentages of frequency or occurrence and
continuous data is presented as means with standard
deviations. Responses were further stratified according
to demographic parameters of practice setting, length
of practice experience, frequency of diabetes patient
interactions, and religious faith. Statistical comparisons
of frequencies utilized χ2 -tests with alpha of less than
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data analyses was conducted using IBM SPSS® for MAC
release 20.0.
Results
The survey remained open between April 8 and June 30,
2012. (3 months prior to Ramadan in July 2012). One
hundred and seventy-eight pharmacists (31%) completed
the questionnaire during this time. Seventeen different
countries of origin were represented. Most had attained
a Baccalaureate as the highest pharmacy degree (156,
87.6%) and over half of respondents had over a decade
of experience (74, 54.1%) (Table 1). The majority (146,
83.0%) identified themselves as Muslim, but very few
were diabetes patients themselves (11, 6.3%). In-patient
(72, 40.5%) and ambulatory care (103, 57.8%) practice
sites were similarly represented.
More pharmacists estimated usual daily interactions
occurring with diabetes patients (91, 51.1%) than in spe-
cifically the 1–2 months directly in advance of and dur-
ing Ramadan (51 each, 28.7%). However, estimates of
weekly interaction leading up to and during Ramadan
increased (46, 25.8% compared to 69, 38,7% and 62,
34.8%). Only very few (4, 2.2%) reported never having
any level of interaction with diabetes patients at anytime
throughout the year. There was no statistically signifi-
cant difference in frequency of interactions with diabetes
patients during Ramadan between the outpatient and in-
patient pharmacists (χ2 (1, N = 178) = 2.23, p = 0.158).Table 1 Subject demographics (n = 178,%)
Gender (n,% female)* 79 (45.4)
Age, years (mean, SD) 35.5 (8.1)
Self-identified as Muslim** 146 (83.0)
Self-identified as having diabetes** 11 (6.3)
Highest pharmacy degree (n,%)
Baccalaureate 156 (87.6)
Masters 13 (7.3)
Doctorate (PhD or PharmD) 7 (3.9)
Year of highest pharmacy degree (n,%)**
Less than 2 years ago 14 (8.0)
2–5 years ago 21 (12.1)
6–10 years ago 45 (25.9)
11–15 years ago 53 (30.5)
More than 15 years ago 41 (23.6)
Current pharmacy practice (n,%)**
Community 65 (36.5)
Clinic (private or public) 38 (21.3)
Hospital (private or public) 72 (40.5)
Other 3 (1.7.)
*n = 175 respondents; **n = 176 respondents.When interacting with patients of varying risks for com-
plications during Ramadan, very few indicated they would
advise low (5%) or moderate (9%) risk diabetes patients
against fasting, but 30% and 60% would discourage those
diabetes patients with high or very high risk profiles, re-
spectively. However, if appropriate dose adjustments and
enhanced self-monitoring were in place for high and very
high risk diabetes patients who still insisted on par-
ticipating in Ramadan, the proportion of pharmacists
who still discouraged fasting decreased to 20% and 38%,
respectively.
The most popular resources for diabetes management
during Ramadan among the respondents were the inter-
net (94, 52.8%); published clinical practice guidelines
(80, 44.9%), and personal opinions or experiences (50,
28.1%). Use of materials distributed by local organiza-
tions (such as the Qatar Diabetes Association) was low
(32, 18%). Twenty percent were aware of and had read
the American Diabetes Association (ADA) Consensus
document on fasting during Ramadan, but only 8.3%
had done so for the decree of the Organization of Islamic
conference, a guidance article arising from symposia be-
tween the Islamic Organization for Medical Sciences and
the International Islamic Fiqh Academy.
One hundred and thirty seven respondents completed
all knowledge questions pertaining to diabetes manage-
ment during Ramadan (Table 2). The mean score was 30
(standard deviation 8) and overall respondent knowledge
category was fair (101, 73.7%). Few pharmacist answers
reflected a “good” score (10, 7.3%), but more pharma-
cists than this scored “poor” (26, 19%). Overall, pharma-
cists performed best when characterizing patient-specific
fasting risks (84% of responses were correct) while diffi-
culty was observed for identifying appropriate patient
advice and education (40% of responses were correct).
Only 43% of correct responses were given for the questions
pertaining to drug dosing adjustment during Ramadan
fasting (over 90% chose incorrect strategies for alter-
ing insulin). There was no statistically significant rela-
tionship between practice site and level of knowledge
(χ2 (1, N = 137) = 0.280 p = 0.644). When logistic regres-
sion was performed, no association between knowledge
and either frequency of interaction with diabetes patients
during Ramadan (p = 0.594) or years of practice experi-
ence (0.185) with knowledge was found.
Pharmacists identified several practical barriers to their
ability to guide diabetes management during Ramadan, in-
cluding inadequate privacy (81, 63%); high workload (51,
39%) and patient volume (66, 51%); patient time con-
straints (59, 44%) or rejection of counseling (28, 21%); and
language barrier (41, 31%). They also faced health system
obstacles, which include lack of access to patient medical
records (60, 50%) or reimbursement for services (51, 39%).
While 24 (20%) were concerned about offering advice that
Table 2 Select knowledge questions regarding fasting diabetes patient care
Question Answer Correct response
(n = 137,%)
Fasting diabetes patient risk stratification
Type 1 diabetes patient High risk 83 (60.5)
Well-controlled patients using metformin Low risk 89 (64.9)
Well-controlled patients using sulfonylurea Moderate risk 44 (32.1)
Patients with history of recurrent hypoglycemia High risk 107 (78.1)
Pregnant patient High risk 84 (61.3)
Elderly patients in ill health High risk 90 (65.7)
Fasting diabetes patient advice
This patient must be referred to a physician for assessment before
embarking on Ramadan fast
All patients 12 (8.7)
This patient can safely fast with appropriate dose adjustment and
frequent monitoring
Moderate and low risk patients 86 (62.8)
This patient must be advised not to fast High risk patient 53 (38.7)
Diabetes patients should break their fast if blood glucose drops to
equal or less than 60 mg/dL (3.3 mmol/L)
True 107 (78.1)
Diabetes patients should break their fast if blood glucose reaches
70 mg/dL (4 mmol/L) in the first few hours after the start of the fast
True 75 (54.7)
Fasting diabetes drug dosing adjustment for fasting
A 55 y.o. with type 2 diabetes takes metformin 500 mg po three
times daily
Take 1 g after Iftar meal & take
500 mg after Suhur meal
69 (50.4)
A 35 y.o. with type 2 diabetes takes sitagliptin po 100 mg once daily Take 100 mg after Iftar meal 82 (59.8)
A 35 y.o. with type 1 diabetes is well-controlled taking 20 units of insulin
(Lantus®) at 9 a.m. and 15 units of insulin (Actrapid®) before each meal
Adjust insulin Lantus to 16 Units
with Suhur meal
10 (7.3)
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agreed with the offered statement that it was not their job
as a pharmacist. In fact 117 (92.9%) believed pharmacists
were qualified to provide counseling (the same proportion
assigned to physicians). This perceived education ability
declined when dietitians (88, 51%) and nurses (46, 27%) in
turn were considered.
Despite such issues, most respondents were motivated
to participate in the management of diabetes patients
during Ramadan and to collaborate in determination of
patient eligibility for safe fasting (105, 85%); adjusting
medication dosage and timings (106, 86%) and develo-
ping educational materials (115, 93%) (Table 3). TheseTable 3 Pharmacist interest in contributing to specific aspect
Ramadan (n = 125,%)
Determining patient risk category for fasting using available expert recomme
Referring all diabetes patients for medical assessment by their physician 2 m
before Ramadan
Recommending dose adjustment for diabetes patients taking insulin
Advising the adjustment of dose and time of administration of oral diabetes
Developing educational material regarding management of hypo- or hyperg
during Ramadanpharmacists expressed positive attitudes towards such ac-
tivities and agreed perceptions and visibility of pharmacist
would be enhanced (117, 94%), patient service satisfaction
improved (118, 94%) and overall role of pharmacist in
multidisciplinary care strengthened (114, 91%).
Discussion
While few studies exist assessing health professional atti-
tudes towards Ramadan fasting of diabetes patients , this
is the first evaluation of how such patients may be ma-
naged by pharmacists within a Middle Eastern context,
which is noteworthy given an estimated 20% of the world’s
1.5 billion Muslims live in this region [10,19-21].s of fasting diabetes patient care during
Strongly agree
or agree
Neither agree
or disagree
Strongly disagree
or disagree
ndations 104 (83.2) 3 (2.4) 4 (3.2)
onths 87 (63.5) 18 (14.4) 18 (14.4)
104 (83.2) 20 (16) 19 (15.2)
agents 107 (85.2) 7 (5.6) 9 (7.2)
lycemia 115 (92) 5 (4) 2 (1.6)
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overall knowledge regarding education and management
of fasting diabetes patient. While it would follow that
Muslim health professionals or pharmacists with diabe-
tes themselves would be more knowledgeable due to
personal acumen, the number of diametric respondents
in our sample were too small to make such comparisons.
Similarly, we could not identify any association between
practice site, experience, or self-reported frequency of
diabetes patient interactions on knowledge.
Deficiencies in correctly answering questions pertaining
to diabetes drug dosing and administration adjustment by
pharmacists is concerning and inadequate medication
counseling has also been reported among physicians. A
small study of 101 French general practitioners identified
few (53%) would adjust insulin dosing for type 1 diabetes
patients during Ramadan and most who would admitted
not offering specific instructions to the patient. Only
12% of these physicians thought to recommend chec-
king blood glucose more frequently [10]. A Canadian
focus group study including 22 health care professionals
found these clinicians expressing uncertainty towards
counseling Muslim diabetes patients during Ramadan, es-
pecially in the presence of divergent patient beliefs [19].
However, a number of published resources exist to
guide management of diabetes patients wishing to par-
ticipate in the Ramadan fast. Only a small proportion of
our cohort of pharmacists were familiar with the two
pivotal guidelines we chose, but they could have been
acquainted with other suitable references. Indeed, the
most commonly cited resource for these pharmacists
was the internet, but we are unable to elaborate on the
nature, appropriateness or quality of information they
purported to locate.
Identified gaps in knowledge and inconsistencies in
care should be viewed as a pressing opportunity for cor-
rection as there is evidence that structured education
programs reduce poor outcomes among fasting diabetes
patients. Multidisciplinary small group education regard-
ing drug dosing, glucose monitoring, diet and physical
activity during Ramadan has been shown to decrease
hypoglycemic and hyperglycemic events in participants
[22,23]. Specific medication management advice for oral
glucose lowering therapies, insulin, and other parenteral
agents (e.g. GLP-1 agonists, amylin analogs) is para-
mount for safe fasting by diabetes patients. If such pro-
grams are to be rightly pursued in the Middle Eastern
region, our study indicates that continuing education
initiatives must be in place for health care providers and
especially pharmacists, to facilitate communication of
accurate and practical health advice. Unfortunately, pa-
tient enrolment capacity and resources available to offer
structured multidisciplinary education programs falls
well below needs of the diabetes population [24]. Studiesof Muslim patients living in North America, Europe, and
Australia describe very low rates of information provi-
ded to them regarding overall health or specific medi-
cation management strategies during the Ramadan fast
[10-12,19,20]. Pharmacists are in a unique position to serve
as a source of information. Previous North American study
estimates diabetes patients see a pharmacist seven times
for every one encounter with another health care provider
and numerous studies have demonstrated pharmacist in-
terventions translating into improvements in diabetes out-
comes [25]. It is not only diabetes patients who would
benefit from greater access to fasting advice and care as a
number of other patient groups at-risk for complications
choose to participate in Ramadan [26,27]. Similarly, fasting
among Muslim populations is not restricted to the holy
month of Ramadan, as religious and personal situations
dictate periods of fasting during other times throughout
the year.
Qatar pharmacists responding to this survey expressed
positive attitudes and motivation to engage patients in
diabetes care during Ramadan. They also demonstrated
realistic expectations about these patients’ desire to ho-
nour their religious obligations, unlike those of health
professionals found in previous studies. Over half (55%)
of a small group of Muslim Turkish patients (n = 36)
residing in Belgium were advised against fasting and
over half (54%) of French general practitioners reported
they discourage fasting among their diabetes patients
[10,12]. Muslim diabetes patients in Australia described
experiences whereby physicians failed to acknowledge
the importance of participating in the Ramadan fast and
therefore abandoned efforts to consult them regarding
this specific care [20]. Our findings may be attributed
to this being the first study in the Middle East among
mostly Muslim health care providers, as well as our strati-
fying diabetes patients according to defined risk categories
when exploring pharmacists recommendations to such
patients for participating in the Ramadan fast.
Practical barriers to Qatar pharmacist provision of dia-
betes care may reflect those of other pharmacists else-
where in the region that are slowly being addressed.
Government-initiated consultation and assessment has
identified that the existing primary care system in Qatar
does not play a sufficiently strong role in preventing,
monitoring, and treating diseases. In response, key ini-
tiatives exist within the country’s recently launched Na-
tional Health Strategy to overhaul the health care system
with a six-year plan to address several deficit areas, which
notably includes medication and patient safety [16]. In
addition, health care policy leaders formally identify the
ideal model of health care delivery must be integrated,
with different health professional providers working co-
hesively and a complementary mandate issued to encou-
rage greater roles for pharmacists. This multidisciplinary
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by the International Diabetes Federation (IDF). Similarly,
a number of studies have demonstrated pharmacist inter-
ventions translates into improvements in diabetes out-
comes [28,29].
Several important limitations to this study merit
consideration. The absence of a formal national phar-
macist registry means our study sample is incomplete.
Non-response error (occurring with survey response
rates <60%) compromises accuracy of our conclusions.
Although this may further contribute to selection bias
and restrict the generalizability of our study findings,
this response rate is consistent with other pharmacist
surveys conducted in Qatar. Higher response rates have
been reported in similar surveys in instances where inves-
tigators visited practice sites (especially community phar-
macies) for face-to-face interviews with the pharmacists,
but this was not feasible given our study’s time frame and
available resources. Generally speaking, those pharmacists
participating in the survey demonstrated an inherent bias
towards sharing opinions on diabetes patient care during
Ramadan and so important views of pharmacists who
were not inclined to answer the questionnaire have been
overlooked by this specific research methodology; there-
fore, our findings regarding knowledge and attitude may
be overestimations and the barriers to reporting underesti-
mations. Another limitation concerns the survey tool it-
self. The questionnaire was not previously validated, but
this is not unusual for the preliminary and exploratory na-
ture of our study [30]. However, it was developed consid-
ering related published qualitative data and we conducted
a pilot study to adapt it to pharmacists’ comprehension.
As for any self-administered questionnaire, accurate re-
sponses may have been impaired by the inability to clarify
question intent with a web-based survey and because
completion was unsupervised and at the respondent’s
leisure, pharmacists could have suspended completing
the questionnaire in order to look up certain answers.
Conclusions
There is a dearth of published international experience
related to multidisciplinary care of diabetes patients dur-
ing Ramadan. This study is the first to describe aspects
of fasting diabetes patient care during Ramadan by phar-
macists in Qatar. Pharmacists can play a pivotal role in
ensuring patients seek medical assessment in advance of
Ramadan to plan their fast and also to advise on dosing
adjustment and glucose management. Educational pro-
grams are necessary to improve pharmacist knowledge
in the provision of accurate advice for fasting diabetes
patients.
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